Quick Takeaways
- RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G for Pacira BioSciences, Inc. Common Stock, par value $0.001 per share (PCRX).
- Disclosed ownership: 5.3%.
- Date of event: 08 Apr 2025.
RENAISSANCE TECHNOLOGIES LLC - 08 Apr 2025 SCHEDULE 13G Report for Pacira BioSciences, Inc. Common Stock, par value $0.001 per share (PCRX)
- Filing Manager
- RENAISSANCE TECHNOLOGIES LLC
- Reporting Manager
- Renaissance Technologies LLC
- Symbol
- PCRX
- Shares outstanding
- 44,861,442 shares
- Disclosed Ownership
- 2,395,601 shares
- Ownership
- 5.3%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Aug 2025, 16:11:45 UTC
- Date of event
- 08 Apr 2025
- Next filing
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RENAISSANCE TECHNOLOGIES LLC disclosed 5.3% ownership in Pacira BioSciences, Inc. Common Stock, par value $0.001 per share (PCRX) on 08 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Aug 2025, 16:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 5.3% | 2,395,601 | 2,395,601 | 0 | Brian Felczak | Chief Financial Officer | |
| Renaissance Technologies Holdings Corporation | 5.3% | 2,395,601 | 2,395,601 | 0 | Brian Felczak | Vice President |